Peripheral and central augmentation indexes in relation to the CYP4F2 polymorphisms in Chinese

Journal of Hypertension

Volumn 29, Issue 3, 2011, Pages 501-508

  Hu, Bang Chuan ^a   Li, Yan ^a   Li, Fa Hong ^a   Zhang, Yi ^a   Sheng, Chang Sheng ^a   Fan, Hong Qi ^a   Wang, Ji Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

arteries; augmentation index; blood pressure; genetics; population

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CYTOCHROME P450 4F2; CYTOCHROME P450 ISOENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUGMENTATION INDEX; CHINESE; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSE PRESSURE; PULSE RATE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

EID: 79951676355     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328342673c     Document Type: Article

References (34)

1. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem 2000; 275:4118-4126. (Pubitemid 30094644)
2. MiyataN,Roman RJ. Roleof 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 2005; 41:175-193.
3. Oyekan A, Balazy M, McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol 1997; 273:R293-R300.
4. Zhang F, Wang MH, Krishna UM, Falck JR, Laniado-Schwartzman M, Nasjletti A. Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 2001; 38:1311-1315. (Pubitemid 34033408)
5. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 1996; 270:R217-R227.
6. Amaral SL, Maier KG, Schippers DN, Roman RJ, Greene AS. CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol 2003; 284:H1528-H1535. (Pubitemid 36460763)
7. Wang JS, Singh H, Zhang F, Ishizuka T, Deng H, Kemp R, et al. Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res 2006; 98:962-969.
8. Singh H, Cheng J, Deng H, Kemp R, Ishizuka T, Nasjletti A, Laniado-Schwartzman M. Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 2007; 50:123-129. (Pubitemid 46986020)
9. Stec DE, Roman RJ, Flasch A, Rieder MJ. Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics 2007; 30:74-81. (Pubitemid 47173292)
10. Liu H, Zhao Y, Nie D, Shi J, Fu L, Li Y, et al. Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension. J Am Soc Nephrol 2008; 19:714-721.
11. Ward NC, Tsai IJ, Barden A, van Bockxmeer FM, Puddey IB, Hodgson JM, Croft KD. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 geneis associated with increased 20-HETE excretion and blood pressure. Hypertension 2008; 51:1393-1398. (Pubitemid 351555955)
12. Fu Z, Nakayama T, Sato N, IzumiY, Kasamaki Y,Shindo A, etal. A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men. Mol Genet Metab 2009; 96:145-147.
13. Fava C, Montagnana M, Almgren P, Rosberg L, Lippi G, Hedblad B, et al. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension 2008; 52:373-380.
14. Fu Z, Nakayama T, Sato N, IzumiY, Kasamaki Y,Shindo A, etal. A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men. Am J Hypertens 2008; 21:1216-1223.
15. Ding H, Cui G, Zhang L, Xu Y, Bao X, Tu Y, et al. Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics 2010; 20:187-194.
16. Safar ME, Lacolley P. Disturbance of macro- and microcirculation: relations with pulse pressure and cardiac organ damage. Am J Physiol Heart Circ Physiol 2007; 293:H1-H7. (Pubitemid 47105053)
17. Agabiti-Rosei E, Mancia G, O'Rourke M, Roman M, Safar M, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007; 50:154-160. (Pubitemid 46986036)
18. Weber T,Auer J, O'Rourke MF, KvasE,Lassnig E,Berent R,EberB.Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109:184-189. (Pubitemid 38114137)
19. Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, et al. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005; 45:980-985. (Pubitemid 40628947)
20. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31:1865-1871.
21. Snieder H, Hayward CS, Perks U, Kelly RP, Kelly PJ, Spector TD. Heritability of central systolic pressure augmentation: a twin study. Hypertension 2000; 35:574-579. (Pubitemid 30108151)
22. Li Y, Staessen JA, Li LH, Gao PJ, Thijs L, Brand E, et al. Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population. Kidney Int 2006; 69:1153-1158.
23. Li LH, Li Y, Wen Y, Wang JG. Anthropometric and metabolic phenotypes in relation to the ADRA2B deletion/insertion polymorphism in Chinese population. J Hypertens 2008; 26:2161-2167.
24. Chen X, Li Y, Sheng CS, Huang QF, Zheng Y, Wang JG. Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting. Am J Hypertens 2010; 23:387-392.
25. Lange A, Gebremedhin D, Narayanan J, Harder D. 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem 1997; 272:27345-27352. (Pubitemid 27452701)
26. Gebremedhin D, Lange AR, Narayanan J, Aebly MR, Jacobs ER, Harder DR. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2\+ current. J Physiol 1998; 507:771-781. (Pubitemid 28143578)
27. Frisbee JC, Roman RJ, Krishna UM, Falck JR, Lombard JH. 20-HETE modulates myogenic response of skeletal muscle resistance arteries from hypertensive Dahl-SS rats. Am J Physiol Heart Circ Physiol 2001; 280:H1066-H1074.
28. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 2000; 87:60-65. (Pubitemid 30456936)
29. Ward NC, Rivera J, Hodgson J, Puddey IB, Beilin LJ, Falck JR, Croft KD. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 2004; 110:438-443. (Pubitemid 38993854)
30. Cheng J, Ou JS, Singh H, Falck JR, Narsimhaswamy D, Pritchard KA Jr, Laniado-Schwartzman M. 20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. Am J Physiol Heart Circ Physiol 2008; 294:H1018-H1026. (Pubitemid 351253316)
31. Inoue K, Sodhi K, Puri N, Gotlinger KH, Cao J, Rezzani R, et al. Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. Am J Physiol Renal Physiol 2009; 297:F875-F884.
32. Ayer JG, Harmer JA, Marks GB, Avolio A, Celermajer DS. Central arterial pulse wave augmentation is greater in girls than boys, independent of height. J Hypertens 2010; 28:306-313.
33. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, Olsen N, et al. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci USA 2001; 98:5211-5216. (Pubitemid 32397108)
34. Nakagawa K, Marji JS, Schwartzman ML, Waterman MR, Capdevila JH. Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol 2003; 284:R1055-R1062. (Pubitemid 36406866)